Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cyriel Y Ponsioen

Showing results (11-20 of 192) with videos related to

Pageof 20
Sort By:
Current Opinion in Gastroenterology|February 20, 2015
Biomarkers for disease progression of primary sclerosing cholangitisElisabeth M G de Vries, Ulrich Beuers, Cyriel Y Ponsioen
Gut|November 21, 2023
Time to focus on the real potential benefit of endobiliary radiofrequency ablation: stent patency in patients with cholangiocarcinomaJeska A Fritzsche, Esmée Smit, Cyriel Y Ponsioen, et al.
Gastrointestinal Endoscopy|February 17, 2024
Brushing beyond biopsies: using the full potential of bile duct brushesJeska A Fritzsche, Cyriel Y Ponsioen, Joanne Verheij, et al.
Hepatology (Baltimore, Md.)|March 26, 2018
Design and Endpoints for Clinical Trials in Primary Sclerosing CholangitisCyriel Y Ponsioen, Keith D Lindor, Ruby Mehta, et al.
European Journal of Gastroenterology & Hepatology|March 13, 2008
Chlamydia infection as risk factor for pediatric biliary tract diseaseCyriel Y Ponsioen, Yvonne Pannekoek, Diego Vergani, et al.
Hepatology (Baltimore, Md.)|September 24, 2019
Letter to the Editor: Fair Comparisons in the Arena of Risk ScoresJunfeng Wang, Ronald B Geskus, Mariska M G Leeflang, et al.
Journal of Hepatology|May 21, 2019
Return to sender: Lymphocyte trafficking mechanisms as contributors to primary sclerosing cholangitisManon de Krijger, Manon E Wildenberg, Wouter J de Jonge, et al.
Therapeutic Advances in Gastroenterology|February 26, 2024
Subcutaneous vedolizumab interval extension in inflammatory bowel disease patients: a case seriesSuzanne I Anjie, Krisztina B Gecse, Cyriel Y Ponsioen, et al.
European Journal of Gastroenterology & Hepatology|November 8, 2017
β-Blocker use is associated with a higher relapse risk of inflammatory bowel disease: a Dutch retrospective case-control studyRose A Willemze, Tinka Bakker, Maria Pippias, et al.
Scandinavian Journal of Gastroenterology|January 17, 2012
The role of antibiotic prophylaxis in endoscopic retrograde cholangiopancreatography; a retrospective single-center evaluationLiesbeth M Kager, Barbara Sjouke, Marre van den Brand, et al.
Pageof 20

Showing results (11-20 of 192) with videos related to

Sort By:
Pageof 20
Current Opinion in Gastroenterology|February 20, 2015
Biomarkers for disease progression of primary sclerosing cholangitisElisabeth M G de Vries, Ulrich Beuers, Cyriel Y Ponsioen
Gut|November 21, 2023
Time to focus on the real potential benefit of endobiliary radiofrequency ablation: stent patency in patients with cholangiocarcinomaJeska A Fritzsche, Esmée Smit, Cyriel Y Ponsioen, et al.
Gastrointestinal Endoscopy|February 17, 2024
Brushing beyond biopsies: using the full potential of bile duct brushesJeska A Fritzsche, Cyriel Y Ponsioen, Joanne Verheij, et al.
Hepatology (Baltimore, Md.)|March 26, 2018
Design and Endpoints for Clinical Trials in Primary Sclerosing CholangitisCyriel Y Ponsioen, Keith D Lindor, Ruby Mehta, et al.
European Journal of Gastroenterology & Hepatology|March 13, 2008
Chlamydia infection as risk factor for pediatric biliary tract diseaseCyriel Y Ponsioen, Yvonne Pannekoek, Diego Vergani, et al.
Hepatology (Baltimore, Md.)|September 24, 2019
Letter to the Editor: Fair Comparisons in the Arena of Risk ScoresJunfeng Wang, Ronald B Geskus, Mariska M G Leeflang, et al.
Journal of Hepatology|May 21, 2019
Return to sender: Lymphocyte trafficking mechanisms as contributors to primary sclerosing cholangitisManon de Krijger, Manon E Wildenberg, Wouter J de Jonge, et al.
Therapeutic Advances in Gastroenterology|February 26, 2024
Subcutaneous vedolizumab interval extension in inflammatory bowel disease patients: a case seriesSuzanne I Anjie, Krisztina B Gecse, Cyriel Y Ponsioen, et al.
European Journal of Gastroenterology & Hepatology|November 8, 2017
β-Blocker use is associated with a higher relapse risk of inflammatory bowel disease: a Dutch retrospective case-control studyRose A Willemze, Tinka Bakker, Maria Pippias, et al.
Scandinavian Journal of Gastroenterology|January 17, 2012
The role of antibiotic prophylaxis in endoscopic retrograde cholangiopancreatography; a retrospective single-center evaluationLiesbeth M Kager, Barbara Sjouke, Marre van den Brand, et al.
Pageof 20